Preston Klassen - President & Head of R & D, Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & Head of R & D, Director
Stock Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Preston Klassen - trading volume in the past year for Regulus Therapeutics Inc.

Holdings reported by Preston Klassen for Regulus Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48.1K $384K $7.99 Jun 3, 2025 Direct
Stock Option (Right to Buy) 675K Jan 30, 2025 Direct Common Stock
Stock Option 0 Jun 25, 2025 Direct Common Stock

Transactions reported by Preston Klassen for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.